Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition

Eur Respir J. 2015 May;45(5):1258-72. doi: 10.1183/09031936.00135814. Epub 2015 Mar 5.

Abstract

In chronic obstructive pulmonary disease (COPD), epithelial changes and subepithelial fibrosis are salient features in conducting airways. Epithelial-to-mesenchymal transition (EMT) has been recently suggested in COPD, but the mechanisms and relationship to peribronchial fibrosis remain unclear. We hypothesised that de-differentiation of the COPD respiratory epithelium through EMT could participate in airway fibrosis and thereby, in airway obstruction. Surgical lung tissue and primary broncho-epithelial cultures (in air-liquid interface (ALI)) from 104 patients were assessed for EMT markers. Cell cultures were also assayed for mesenchymal features and for the role of transforming growth factor (TGF)-β1. The bronchial epithelium from COPD patients showed increased vimentin and decreased ZO-1 and E-cadherin expression. Increased vimentin expression correlated with basement membrane thickening and airflow limitation. ALI broncho-epithelial cells from COPD patients also displayed EMT phenotype in up to 2 weeks of culture, were more spindle shaped and released more fibronectin. Targeting TGF-β1 during ALI differentiation prevented vimentin induction and fibronectin release. In COPD, the airway epithelium displays features of de-differentiation towards mesenchymal cells, which correlate with peribronchial fibrosis and airflow limitation, and which are partly due to a TGF-β1-driven epithelial reprogramming.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Airway Obstruction
  • Antigens, CD
  • Bronchi / cytology
  • Cadherins / metabolism
  • Cell Dedifferentiation*
  • Epithelial Cells / cytology
  • Epithelial-Mesenchymal Transition*
  • Female
  • Fibronectins / metabolism
  • Fibrosis / pathology
  • Fibrosis / physiopathology
  • Gene Expression Regulation*
  • Humans
  • In Vitro Techniques
  • Lung / pathology
  • Male
  • Middle Aged
  • Phenotype
  • Pulmonary Disease, Chronic Obstructive / physiopathology*
  • Respiratory Mucosa / metabolism
  • Transforming Growth Factor beta1 / metabolism
  • Vimentin / metabolism
  • Zonula Occludens-1 Protein / metabolism

Substances

  • Antigens, CD
  • CDH1 protein, human
  • Cadherins
  • Fibronectins
  • TGFB1 protein, human
  • TJP1 protein, human
  • Transforming Growth Factor beta1
  • Vimentin
  • Zonula Occludens-1 Protein